Nantahala Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Nantahala Capital Management’s Portfolio VIRX Stock Details VIRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell
2020 Q3	$865K	Sell
2020 Q2	$2.52M	Hold
2020 Q1	$3.97M	Buy
2019 Q4	$2.96M	Buy
2019 Q3	$5.54M	Buy
2019 Q2	$3.24M	Buy